Nanotheranostics · 2022 · 24 citations · 34 references
PharmacyOncologyPharmacologyDrug DeliveryTumor ImmunologyTumor MicroenvironmentDrug EncapsulationLiposomal FormulationsLiposome-based DeliveryNanomedicinePharmacokinetics Of Anticancer DrugsTumor Microenvironment ModulationAnticancer ActivityAnticancer ChemotherapyImmunosuppressive MicroenvironmentLiposomal Co-deliveryLiposomal Delivery SystemsPegylated LiposomesTumor Microenvironment EffectsTumor Microenvironment Responsiveness
We have previously shown that alendronate, an amino-bisphosphonate, when reformulated in liposomes, can significantly enhance the efficacy of cytotoxic chemotherapies and help remodel the immunosuppressive tumor microenvironment towards an immune-permissive milieu resulting in increased anticancer efficacy. In addition, we have previously shown that the strong metal-chelating properties of alendronate can be exploited for nuclear imaging of liposomal biodistribution. To further improve anticancer efficacy, a pegylated liposome formulation co-encapsulating alendronate and doxorubicin (PLAD) has been developed. In this study, we examined the effects of PLAD on the tumor immunologic milieu in a mouse fibrosarcoma model in which the tumor microenvironment is heavily infiltrated with tumor-associated macrophages (TAM) that are associated with poor prognosis and treatment resistance.
34
Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2018 · 990 citations · Full text
Medicine, Oncology, Pharmacology +15
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 862 citations · Full text
Life Sciences, Immunology, Oncology +14